Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (26)

« Back to Publications

Long-persisting SARS-CoV-2 spike-specific CD4+ T cells associated with mild disease and increased cytotoxicity post COVID-19

Liu G. et al, (2025), Nature Communications, 16

Persistence of inflammatory and vascular mediators 5 months after hospitalization with COVID-19 infection

Melhorn J. et al, (2023), Frontiers in Medicine, 10

Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19

Kotanidis CP. et al, (2022), The Lancet Digital Health, 4, e705 - e716

Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review

Crossingham I. et al, (2022), BMJ Evidence-Based Medicine, 27, 178 - 184

Divergent trajectories of antiviral memory after SARS-CoV-2 infection

Tomic A. et al, (2022), Nature Communications, 13

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Ahern DJ. et al, (2022), Cell, 185, 916 - 938.e58

Memory cytotoxic SARS-CoV-2 spike protein-specific CD4+ T cells associate with viral control

Dong T. et al, (2022)

An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

Peng Y. et al, (2022), Nature Immunology, 23, 50 - 61

Spontaneous pneumomediastinum, subcutaneous emphysema and pneumothorax in non-intubated patients with COVID-19 pneumonitis: a retrospective case note review of a single centre experience

Karwal R. et al, (2022), EUROPEAN RESPIRATORY JOURNAL, 60

Persistence of inflammatory and vascular damage mediators 5 months after acute COVID-19

Petousi N. et al, (2022), EUROPEAN RESPIRATORY JOURNAL, 60

Improved COVID-19 outcomes in a large non-invasive respiratory support cohort despite emergence of the alpha variant

Turnbull CD. et al, (2021), BMJ Open Respiratory Research, 8, e001044 - e001044

Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern

Skelly DT. et al, (2021), Nature Communications, 12

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Ahern DJ. et al, (2021)

Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma

Crossingham I. et al, (2021), Cochrane Database of Systematic Reviews, 2021

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abaleke E. et al, (2021), The Lancet, 397, 605 - 612

Load More